Bettiol A - Search Results

1

Risk of Hospitalization for Adverse Drug Events in Women and Men: A Post Hoc Analysis of an Active Pharmacovigilance Study in Italian Emergency Departments.

Crescioli G, Boscia E, Bettiol A, Pagani S, Spada G, Vighi GV, Bonaiuti R, Venegoni M, Vighi GD, Vannacci A, Lombardi N, On Behalf Of The MEREAFaPS Study Group. Crescioli G, et al. Among authors: bettiol a. Pharmaceuticals (Basel). 2021 Jul 15;14(7):678. doi: 10.3390/ph14070678. Pharmaceuticals (Basel). 2021. PMID: 34358104 Free PMC article.

2

Microbiome in Behcet's syndrome.

Bettiol A, Emmi G, Low L, Sofi F, Wallace GR. Bettiol A, et al. Clin Immunol. 2023 May;250:109304. doi: 10.1016/j.clim.2023.109304. Epub 2023 Mar 30. Clin Immunol. 2023. PMID: 37003591 Review.

3

Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia.

Bettiol A, Marconi E, Lombardi N, Crescioli G, Gherlinzoni F, Walley T, Vannacci A, Chinellato A, Giusti P. Bettiol A, et al. Clin Drug Investig. 2018 Sep;38(9):837-844. doi: 10.1007/s40261-018-0676-7. Clin Drug Investig. 2018. PMID: 30043130 Clinical Trial.

4

Prescribing patterns of allopurinol and febuxostat according to directives on the reimbursement criteria and clinical guidelines: analysis of a primary care database.

Marconi E, Bettiol A, Lombardi N, Crescioli G, Parretti L, Vannacci A, Medea G, Cricelli C, Lapi F. Marconi E, et al. Among authors: bettiol a. Curr Med Res Opin. 2019 Apr;35(4):683-688. doi: 10.1080/03007995.2018.1541315. Epub 2018 Nov 26. Curr Med Res Opin. 2019. PMID: 30358452

5

The Impact of Previous Pregnancy Loss on Lactating Behaviors and Use of Herbal Medicines during Breastfeeding: A Post Hoc Analysis of the Herbal Supplements in Breastfeeding InvesTigation (HaBIT).

Bettiol A, Lombardi N, Marconi E, Crescioli G, Bonaiuti R, Maggini V, Gallo E, Mugelli A, Firenzuoli F, Ravaldi C, Vannacci A. Bettiol A, et al. Evid Based Complement Alternat Med. 2018 Nov 8;2018:1035875. doi: 10.1155/2018/1035875. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30532793 Free PMC article.

6

Galenic Preparations of Therapeutic Cannabis sativa Differ in Cannabinoids Concentration: A Quantitative Analysis of Variability and Possible Clinical Implications.

Bettiol A, Lombardi N, Crescioli G, Maggini V, Gallo E, Mugelli A, Firenzuoli F, Baronti R, Vannacci A. Bettiol A, et al. Front Pharmacol. 2019 Jan 17;9:1543. doi: 10.3389/fphar.2018.01543. eCollection 2018. Front Pharmacol. 2019. PMID: 30705629 Free PMC article.

7

Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials.

Lombardi N, Crescioli G, Bettiol A, Ravaldi C, Vannacci A. Lombardi N, et al. Among authors: bettiol a. Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):437-438. doi: 10.1002/pds.4740. Epub 2019 Mar 7. Pharmacoepidemiol Drug Saf. 2019. PMID: 30847998 No abstract available.

8

Prescribing Trends of Codeine-containing Medications and Other Opioids in Primary Care After A Regulatory Decision: An Interrupted Time Series Analysis.

Lombardi N, Vannacci A, Bettiol A, Marconi E, Pecchioli S, Magni A, Cricelli C, Lapi F. Lombardi N, et al. Among authors: bettiol a. Clin Drug Investig. 2019 May;39(5):455-462. doi: 10.1007/s40261-019-00767-8. Clin Drug Investig. 2019. PMID: 30852809

9

Safety of complementary and alternative medicine in children: A 16-years retrospective analysis of the Italian Phytovigilance system database.

Lombardi N, Crescioli G, Bettiol A, Menniti-Ippolito F, Maggini V, Gallo E, Mugelli A, Vannacci A, Firenzuoli F. Lombardi N, et al. Among authors: bettiol a. Phytomedicine. 2019 Aug;61:152856. doi: 10.1016/j.phymed.2019.152856. Epub 2019 Feb 5. Phytomedicine. 2019. PMID: 31035051

10

Nomograms predictive for oncological outcomes in malignant parotid tumours: recurrence and mortality rates of 228 patients from a single institution.

Mannelli G, Alessandro F, Martina F, Lorenzo C, Bettiol A, Vannacci A, Oreste G. Mannelli G, et al. Among authors: bettiol a. Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4491-4503. doi: 10.1007/s00405-019-05556-9. Epub 2019 Jul 25. Eur Arch Otorhinolaryngol. 2022. PMID: 31346721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page